# PEMAZYRE

NDC: 50881-028
Generic name: pemigatinib
Labeler / Manufacturer: Incyte Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200417

FDA application: NDA213736

## Active ingredients

- PEMIGATINIB: 13.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50881-028"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50881-028
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e1f2222-1d89-4e63-989c-ccebe2ab1eb4